Total Payments
$4,911
2024 Payments
$1,161
Companies
37
Transactions
349
Medicare Patients
1,841
Medicare Billing
$220,805
Payment Breakdown by Category
Food & Beverage$4,899 (99.8%)
Education$12.16 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,899 | 348 | 99.8% |
| Education | $12.16 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $988.26 | 80 | $0 (2024) |
| Novo Nordisk Inc | $662.15 | 52 | $0 (2024) |
| Lilly USA, LLC | $437.19 | 28 | $0 (2024) |
| PFIZER INC. | $433.24 | 35 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $412.57 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $274.82 | 18 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $167.30 | 11 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $146.50 | 8 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $126.82 | 8 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $123.86 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,161 | 81 | Novo Nordisk Inc ($243.12) |
| 2023 | $1,359 | 93 | Novo Nordisk Inc ($247.19) |
| 2022 | $1,135 | 78 | ABBVIE INC. ($311.22) |
| 2021 | $1,256 | 97 | AbbVie Inc. ($254.35) |
All Payment Transactions
349 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Obesity | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.71 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: PAIN | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Neuropsychiatry | ||||||
| 11/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Neuropsychiatry | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: PAIN | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: PAIN | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 404 | 719 | $101,147 | $44,561 |
| 2022 | 9 | 411 | 700 | $139,628 | $49,658 |
| 2021 | 8 | 440 | 824 | $174,585 | $61,751 |
| 2020 | 10 | 586 | 1,012 | $166,210 | $64,835 |
Total Patients
1,841
Total Services
3,255
Medicare Billing
$220,805
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 88 | 228 | $27,360 | $18,153 | 66.3% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 85 | 173 | $27,740 | $7,739 | 27.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $14,175 | $6,693 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 59 | $11,800 | $3,926 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 78 | $11,310 | $3,712 | 32.8% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 20 | 20 | $4,267 | $2,109 | 49.4% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 17 | 17 | $2,909 | $1,397 | 48.0% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 25 | 41 | $1,025 | $499.38 | 48.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 19 | 19 | $456.00 | $285.95 | 62.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 21 | $105.00 | $46.20 | 44.0% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 78 | 164 | $37,720 | $13,493 | 35.8% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 78 | 163 | $30,155 | $9,134 | 30.3% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 62 | 68 | $21,760 | $7,974 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $11,700 | $5,645 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 87 | $17,400 | $5,603 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 109 | $15,805 | $5,224 | 33.1% |
| 99328 | New patient custodial care facility, group care, or assisted living visit, typically 75 minutes | Office | 2022 | 15 | 15 | $4,050 | $2,017 | 49.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 21 | 30 | $750.00 | $386.20 | 51.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $288.00 | $180.72 | 62.8% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 78 | 208 | $47,840 | $17,078 | 35.7% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 94 | 210 | $38,850 | $11,549 | 29.7% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2021 | 73 | 91 | $29,120 | $9,471 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 105 | $20,190 | $7,101 | 35.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 45 | 45 | $10,935 | $6,279 | 57.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 123 | $17,435 | $5,207 | 29.9% |
About Amanda Mcgee, FNPC
Amanda Mcgee, FNPC is a Primary Care healthcare provider based in Morganton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962492082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Mcgee, FNPC has received a total of $4,911 in payments from pharmaceutical and medical device companies, with $1,161 received in 2024. These payments were reported across 349 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,899).
As a Medicare-enrolled provider, Mcgee has provided services to 1,841 Medicare beneficiaries, totaling 3,255 services with total Medicare billing of $220,805. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Family
- Location Morganton, NC
- Active Since 10/28/2005
- Last Updated 01/12/2018
- Taxonomy Code 261QP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962492082
Products in Payments
- VRAYLAR (Drug) $555.77
- NURTEC ODT (Drug) $528.08
- Ozempic (Drug) $314.35
- AUSTEDO (Drug) $309.50
- UBRELVY (Drug) $193.33
- Rybelsus (Drug) $191.53
- TRULICITY (Drug) $189.70
- BREZTRI (Drug) $159.49
- Kerendia (Drug) $126.82
- ZENPEP (Drug) $123.86
- TRINTELLIX (Drug) $123.76
- EMGALITY (Drug) $121.37
- QULIPTA (Drug) $119.94
- REXULTI (Drug) $119.48
- COMIRNATY (Biological) $118.76
- MOUNJARO (Drug) $97.42
- Austedo XR (Drug) $84.01
- FARXIGA (Drug) $83.91
- Myrbetriq (Drug) $73.40
- LINZESS (Drug) $71.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.